A decision is expected in the fourth quarter of 2025.

The Bagsvaerd, Denmark, company said that if the application is approved, Wegovy would become the first oral formulation of a ...

The U.S. Food and Drug Administration has accepted Novo Nordisk's marketing application for an oral version of its ...

The company’s health services division Evernorth is doubling down on a reliable growth area: assuaging payer concerns around ...

Eric Stonestreet, the actor known for playing Cam on Modern Family, is teaming up with his mother to sell the weight-loss ...

Ozempic’s popularity for weight loss is growing, and according to a 2024 survey from KFF, about two in five adults in the US ...

GLP-1 drug prices are falling. That's good news for patients, but perhaps not such good news for pharmaceutical stock ...

Cigna, which comprises the Evernorth Health Services division and the Cigna Healthcare insurance business, reported a 19% ...

Kyle Richards’ daughter Sophia Umansky detailed the unexpected side effects that surfaced four months after she started ...

The World Health Organization plans to officially back the use of weight-loss drugs to treat obesity in adults for the first ...

Losing even a moderate amount of weight is associated with reduced progression of diabetes, improved blood pressure and HDL ...

Taking a glucagon-like peptide 1 (GLP-1) medication can be life-changing, but it comes with a learning curve. Along with ...